A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial
- DOI
- 10.1101/2025.04.18.25326082
- Published
- 2025-04-20
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1101/2025.04.18.25326082,
title = {A Translational Neuroscience \& Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial},
author = {Clara Fonteneau and Zailyn Tamayo and Ally Price and Lining Pan and Yvette Afriyie-Agyemang and Shriya Agrawal and Audrey Butler and Courtney Cail and Monica Calkins and Srinivas Chakilam and Kimberlee Forselius-Bielen and Geena Fram and Allea Frazier and Roberto Gil and Preetika Govil and David L. Gray and Jack Grinband and Ruben C. Gur and Natalka K. Haubold and Zachary Heffernan and Larry Kegeles and Christian Kohler and Chenyang Lin and Jing Lu and Megan Mayer and Phuong Pham and Greg Perlman and Masih Rahmati and Mohini Ranganathan and Nicole P. Santamauro and Christopher T. Schutte and Alexandria Selloni and Jared Van Snellenberg and Toral Surti and Daniel H. Wolf and Catrin Zharyy and Unknown and Anissa Abi-Dargham and Raquel E. Gur and Jeffrey A. Lieberman and Joshua T. Kantrowitz and Alan Anticevic and Youngsun T. Cho and John H. Krystal},
year = {2025},
doi = {10.1101/2025.04.18.25326082},
url = {https://doi.org/10.1101/2025.04.18.25326082}
}RIS
TY - JOUR TI - A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial AU - Clara Fonteneau AU - Zailyn Tamayo AU - Ally Price AU - Lining Pan AU - Yvette Afriyie-Agyemang AU - Shriya Agrawal AU - Audrey Butler AU - Courtney Cail AU - Monica Calkins AU - Srinivas Chakilam AU - Kimberlee Forselius-Bielen AU - Geena Fram AU - Allea Frazier AU - Roberto Gil AU - Preetika Govil AU - David L. Gray AU - Jack Grinband AU - Ruben C. Gur AU - Natalka K. Haubold AU - Zachary Heffernan AU - Larry Kegeles AU - Christian Kohler AU - Chenyang Lin AU - Jing Lu AU - Megan Mayer AU - Phuong Pham AU - Greg Perlman AU - Masih Rahmati AU - Mohini Ranganathan AU - Nicole P. Santamauro AU - Christopher T. Schutte AU - Alexandria Selloni AU - Jared Van Snellenberg AU - Toral Surti AU - Daniel H. Wolf AU - Catrin Zharyy AU - Unknown AU - Anissa Abi-Dargham AU - Raquel E. Gur AU - Jeffrey A. Lieberman AU - Joshua T. Kantrowitz AU - Alan Anticevic AU - Youngsun T. Cho AU - John H. Krystal PY - 2025 DO - 10.1101/2025.04.18.25326082 UR - https://doi.org/10.1101/2025.04.18.25326082 ER -
APA
Fonteneau, C., Tamayo, Z., Price, A., Pan, L., Afriyie-Agyemang, Y., Agrawal, S., Butler, A., Cail, C., Calkins, M., Chakilam, S., Forselius-Bielen, K., Fram, G., Frazier, A., Gil, R., Govil, P., Gray, D. L., Grinband, J., Gur, R. C., Haubold, N. K., Heffernan, Z., Kegeles, L., Kohler, C., Lin, C., Lu, J., Mayer, M., Pham, P., Perlman, G., Rahmati, M., Ranganathan, M., Santamauro, N. P., Schutte, C. T., Selloni, A., Snellenberg, J. V., Surti, T., Wolf, D. H., Zharyy, C., Unknown, Abi-Dargham, A., Gur, R. E., Lieberman, J. A., Kantrowitz, J. T., Anticevic, A., Cho, Y. T., & Krystal, J. H. (2025). A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial. https://doi.org/10.1101/2025.04.18.25326082
Source records
- crossref · retrieved 2026-11-10T21:15:43.104Z